Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.
Migliavacca M, Assanelli A, Ferrua F, Cicalese MP, Biffi A, Frittoli M, Silvani P, Chidini G, Calderini E, Mandelli A, Camporesi A, Milani R, Farinelli G, Nicoletti R, Ciceri F, Aiuti A, Bernardo ME.
Migliavacca M, et al. Among authors: ciceri f.
J Allergy Clin Immunol. 2016 Jun;137(6):1913-1915.e2. doi: 10.1016/j.jaci.2016.01.033. Epub 2016 Apr 4.
J Allergy Clin Immunol. 2016.
PMID: 27056268
Free PMC article.
Clinical Trial.
No abstract available.